Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Retinoids may help treat lupus nephritis and reduce steroid use.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Enhancing Tregs can protect against alopecia areata.

The research developed new fortilin protein constructs for potential heart disease treatments.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Ruxolitinib cream may help treat severe hair loss in children.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Promising cancer treatments were found, but the manufacturer closed.

Baricitinib effectively treats severe alopecia for up to 104 weeks.